sulfinpyrazone has been researched along with Disease, Pulmonary in 2 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hilliker, KS | 1 |
| Roth, RA | 1 |
| Fountain, SW | 1 |
| Martin, BA | 1 |
| Musclow, CE | 1 |
| Cooper, JD | 1 |
2 other studies available for sulfinpyrazone and Disease, Pulmonary
| Article | Year |
|---|---|
Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone.
Topics: Animals; Body Weight; Cardiomegaly; Dexamethasone; Heart Diseases; Hydralazine; L-Lactate Dehydrogen | 1984 |
Pulmonary leukostasis and its relationship to pulmonary dysfunction in sheep and rabbits.
Topics: Animals; Blood Pressure; Carbon Dioxide; Cardiac Output; Cell Aggregation; Complement C3; Complement | 1980 |